Article Per Year (5 Year)
p-Index From 2021 - 2026
3.014
P-Index
This Author published in this journals
All Journal Medika Tadulako Farmasains : Jurnal Ilmiah Ilmu Kefarmasian Journal of Economic, Bussines and Accounting (COSTING) PENDIPA Journal of Science Education JSFK (Jurnal Sains Farmasi & Klinis) JURNAL PENDIDIKAN TAMBUSAI JURNAL FARMASIMED (JFM) The International Journal of Business Review (The Jobs Review) JPGI (Jurnal Penelitian Guru Indonesia) Jurnal Riset Kefarmasian Indonesia Science Midwifery MAHESA : Malahayati Health Student Journal SOCIAL CLINICAL PHARMACY INDONESIA JOURNAL International Journal of Science and Society (IJSOC) Sciences of Pharmacy
Saragi, Sahat
Unknown Affiliation
Biochemistry, Genetics & Molecular Biology Chemical Engineering, Chemistry & Bioengineering Chemistry Dentistry Economics, Econometrics & Finance Education Health Professions Immunology & microbiology Materials Science & Nanotechnology Mathematics Medicine & Pharmacology Nursing Public Health Social Sciences Veterinary

Published : 24 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 24 Documents
Search

 1   2   3 
HUBUNGAN LAMA KERJASAMA TERHADAP KEPERCAYAAN PELANGGAN PBF BINA PRIMA SEJATI Brahmono, Umul Angga; Saragi, Sahat; Andayani, Nurita
Jurnal Riset Kefarmasian Indonesia Vol. 5 No. 1 (2023): Jurnal Riset Kefarmasian Indonesia
Publisher : APDFI (Asosiasi Pendidikan Diploma Farmasi Indonesia)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33759/jrki.v5i1.324

Abstract

The large number of pharmacies is not proportional to the number of PBF in DKI Jakarta, causing intense competition in drug distribution activities to pharmacies. The main concept of partnership or cooperation with customers is trust. Building trust will have an impact on bringing loyalty to continue working with the company. This study aims to determine the effect of the length of cooperation between PBF and pharmacies on customer trust. This research was conducted by survey and observation methods. The sampling technique was carried out by Probability Sampling with a Proportionate Stratified Random Sampling approach in order to obtain 69 pharmacies. The results showed that the length of cooperation from 69 pharmacies was 7-12 months for 1 pharmacy, 13-24 months for 8 pharmacies and >24 months for 60 pharmacies. The highest pharmacy confidence level is 85.51%, moderate is 13.04% and low is 1.45%. Based on the results of the Pearson correlation test, a sig value of >0.05 indicates that there is no relationship between length of cooperation and customer trust in PBF. This shows that there is no relationship between the length of time of cooperation with the level of trust the Pharmacy has in PBF Bina Prima Sejati.
GAMBARAN EFEKTIFITAS PENERAPAN 5 STANDAR OPERASIONAL PROSEDUR (SOP) PELANGGAN DI PBF BINA PRIMA SEJATI JAKARTA BARAT Brahmono, Angga; Saragi, Sahat; Andayani, Nurita
Jurnal Riset Kefarmasian Indonesia Vol. 5 No. 3 (2023): Jurnal Riset Kefarmasian Indonesia
Publisher : APDFI (Asosiasi Pendidikan Diploma Farmasi Indonesia)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33759/jrki.v5i3.396

Abstract

The CDOB guidelines state that in implementing CDOB, one must have an SOP. SOP formulation as a benchmark in assessing the effectiveness and efficiency of agency performance in implementing its work program. The principle of preparing SOPs must also be oriented to the parties served so that they can provide satisfaction to users. It is important for PBF to pay attention to the quality of services provided to pharmacies because it can lead to satisfaction and a positive attitude from customers. The purpose of this study was to determine the effectiveness of implementing 5 customer SOPs at PBF Bina Prima Sejati. The method used in this research is descriptive method with observation. The results of the study showed that the results of the SOP for distributing drugs to new pharmacies were 93.65% carried out by officers; SOP for handling customer complaints has only been implemented 43.81%; SOP for handling counterfeit and suspected counterfeit drugs has only been implemented 80.47%; The SOP for handling new returned drugs was 98.64% carried out by officers and the SOP for handling new recalled drugs was 89.68% carried out by officers. Overall 5 SOPs related to new customers 81.25% are carried out by officers. If it is seen that the effective implementation of the SOP must be 100%, then the implementation of the 5 customer SOPs is not effectively carried out by officers.
Drug Interactions in Type 2 Diabetes and Hypertension Patients at RSUD dr. Zainoel Abidin, Banda Aceh Saragi, Sahat; Fitriana, Ruhul
Jurnal FARMASIMED (JFM) Vol 8 No 2 (2026): Jurnal Farmasimed (JFM)
Publisher : Fakultas Farmasi Institut Kesehatan Medistra Lubuk Pakam

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.35451/34ygtz72

Abstract

DM(DM) is one of the diseases with a high prevalence. Indonesia ranks fifth in the world, contributing 90–95% of all diabetes cases through type 2 DM. This study aimed to identify the characteristics (age, gender, education, occupation), number of medications used, potential drug interactions, severity level of drug interactions, and the association between the number of medications and the potential for drug interactions. This was an observational study with a descriptive quantitative design and retrospective data collection. The sample consisted of 349 patients who met the inclusion criteria: patients with type 2 DM and hypertension, aged ≥18 years, receiving outpatient care at Dr. Zainoel Abidin General Hospital in 2021, and using at least one type 2 DM drug and one antihypertensive drug. The results showed that most patients were aged 56–65 years (36%), male (53.6%), had senior high school education or equivalent (46.4%), and worked as civil servants (25.8%). A total of 56.2% of patients used ≥5 medications. The most commonly used antidiabetic drug was insulin (66.44%), the most common antihypertensive was ARB (37.95%), cardiovascular prevention was dominated by statins (87.24%), and the most frequently used non-antidiabetic and non-antihypertensive drug was PPI (25.19%). A total of 92.8% of patients experienced potential drug interactions, with 1,250 total interactions. The majority were of moderate severity (85.8%) with a pharmacodynamic mechanism (78.8%). The most frequent potential interaction occurred between amlodipine and atorvastatin (3.68%). Chi-square test results showed a statistically significant relationship between the number of medications used and the potential risk of drug interactions.
PENGARUH PROLANIS TERHADAP OUTCOME KLINIK PASIEN DIABETES MELITUS TIPE 2 DI PUSKESMAS KECAMATAN PULOGADUNG Tanty, Herty Nur; Anggriani, Yusi; Saragi, Sahat
Farmasains : Jurnal Ilmiah Ilmu Kefarmasian Vol. 6 No. 1 (2019)
Publisher : Universitas Muhammadiyah Prof. DR. HAMKA

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22236/farmasains.v6i1.2978

Abstract

Prolanis merupakan program dari PT. Askes (Persero) dalam upaya penanganan penyakit kronis pada pasien DM tipe 2. Jumlah pasien DM yang tergabung di Prolanis setiap tahunnya terus bertambah akan tetapi tidak disertai dengan kontinuitas kunjungan. Berdasarkan data jumlah peserta prolanis DM tipe 2 di Puskesmas Kecamatan Pulogadung yang sudah mengikuti prolanis minimal 6 bulan sejumlah 284 pasien. Tujuan penelitian ini adalah untuk mendapatkan perbedaan outcome klinik pasien prolanis dibanding pasien non prolanis dan mendapatkan hubungan antara kepatuhan dengan outcome klinik. Penelitian ini menggunakan desain cross sectional dengan alur penelitian retrospektif sebelum dan sesudah pasien bergabung dengan prolanis. Data diperoleh dari rekam medik dan data kunjungan pasien dengan menggunakan teknik total sampling. Hasil penelitian menunjukkan adanya perbedaan outcome klinik pasien DM tipe 2 yang mengikuti prolanis dengan pasien DM tipe 2 yang tidak mengikuti prolanis (p<0,05). Hasil penelitian menunjukkan adanya hubungan antara tingkat kepatuhan kunjungan dengan outcome klinik pasien prolanis dan non prolanis (p<0.05).
Co-Authors , Aritonang, Aritonang Afriza, Reinaldy Yuda Andayani, Nurita Aritonang, Aritonang Atikah, Hibatul Wafi Brahmono, Angga Brahmono, Umul Angga Derriawan Derriawan, Derriawan Fatroni, Hanif Fitriana, Ruhul Harahap, Diah Lestari Ikbal, Muh Indra, Hivzil Jamaludin, Aditya Juminar, St Ratna Lies Putriana Martirini, Agnes Stefania P., Embriana Dinar Putriani, Rizka Rafrini Amyulianthy Rahmatika, Lora Ramadaniati, Hesty Utami Sembiring, Grace Faskarina Sitanggang, Maura Linda Sri Widyastuti Sukatin, Sukatin Tanty, Herty Nur Wijayanti, Fitri Dwi Yazid, Ricky Chaerul Yusi Anggriani